SPY
749.60
−0.63%
QQQ
674.25
−0.83%
BTC/USD
65,082.00
−0.36%
DIA
521.21
−0.37%
GLD
355.70
+0.07%
TLT
79.42
+0.05%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Large Cap
Consumer Tech (Nov 9-13): Jensen Resigns From Nvidia Amid Affair Controvery, Microsoft Faces Massive Outage & More
Earnings Volatility Watch: Nvidia Stock Could Swing 9% Without Jensen Huang, Yet This Newly Listed Tech Name Is Priced For 21.7%
NVDA, AMD, CRWV and More: 5 Stocks Investors Couldn’t Stop Buzzing About This Week
Earnings Volatility Watch: Nvidia Stock Could Swing 9% Without Jensen Huang, Yet This Newly Listed Tech Name Is Priced For 21.7%
NVDA, AMD, CRWV and More: 5 Stocks Investors Couldn’t Stop Buzzing About This Week
Nvidia Loses Its Founder, AMD and Broadcom Take the Crown: This Week on Wall Street
Cerebras Stock Jumps on Q3 Cloud Revenue Up 265%, Raised Outlook (CORRECTED)
Nvidia Loses Its Founder, AMD and Broadcom Take the Crown: This Week on Wall Street
Cerebras Stock Jumps on Q3 Cloud Revenue Up 265%, Raised Outlook (CORRECTED)
Elon Musk's SpaceX–Tesla Merger 'Almost Inconceivable' to Avoid, Biographer Says
Jensen Huang Joins Wall Street’s Fallen-Founder Hall of Fame: 13 Founders Who Fell Before Him
Read More...
Large Cap Recent News
AMD Stock Has Outrun Nvidia 5X Since 2024. But There’s a Valuation Catch
AMD has outperformed Nvidia 5X since 2024, but its forward P/E is more than three times higher. Can growth justify the premium?
AMD Sinks 10.5% as Chip Rally Unwinds, Nasdaq 100 Falls 1.7%: Stock Market Today
AMD lost about $100 billion as traders unwound the post-Huang chip rotation, Nvidia's China scandal deepened and Cisco slid on margins. QQQ fell 1.7%.
Nvidia Courting a Former Insider: Arm CEO Rene Haas
Nvidia reportedly approached Arm CEO Rene Haas as a potential successor to Jensen Huang, with CFO Colette Kress serving as interim CEO amid turmoil.
Novo Nordisk Scores EU Win For Hemophilia Drug, Advances Sickle Cell Treatment Toward Approval
Novo Nordisk secures EU approval for hemophilia therapy Frehemgo and submits US and European applications for sickle cell drug etavopivat.
Regeneron Drug Lowers Standing Heart Rate And Improves Symptoms In Heart Disease Study
Regeneron reports Phase 2 PINNACLE trial data showing baloncibart reduces standing heart rate and improves symptoms in adults with POTS.
What's Going on with Chevron Shares on Friday?
Chevron restarts its Ralston, Iowa, biodiesel facility under an agreement with Landus Cooperative, bringing nearly 42 million gallons of annual capacity back online.
Bessent Points Finger at Lutnick as White House Feud Over Nvidia Erupts
Scott Bessent publicly blamed Howard Lutnick over the Nvidia China chip scandal as Lutnick’s exit odds surged
UnitedHealthcare Policy Assessment Urges Clearer Provider Guidance
External consultants praise UnitedHealthcare's evidence-based medical policy process while recommending clearer templates and documentation.
Huang Is Out of the Game: Now 20% of Nvidia's Asian Revenue Could Be at Risk
Jensen Huang's exit puts Nvidia's Asian revenue under scrutiny as Megaspeed probes test how much Taiwan and Singapore sales served China.
Michael Burry Says WSJ Missed the Real Nvidia Story
Michael Burry says reporters missed Nvidia’s deeper risks, including chip alternatives, excess supply and AI bubble concerns.
Microsoft Just Relived the CrowdStrike Nightmare. But There’s One Crucial Difference
Microsoft's outage recalls CrowdStrike's 2024 meltdown, but the two failures expose different risks in enterprise technology.
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Pfizer will stop selling Premarin cream and tablets in Canada after an internal review, adding strain to ongoing menopause drug shortages.
What's Going On With ExxonMobil Stock Friday?
ExxonMobil (XOM) advances a $12.5B Guyana project set for 2030. Explore XOM's latest Q3 earnings beat, analyst forecasts, and key SMA levels.
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Loading...
Loading watchlists...